100% agree mate, hopefully funding will be a non issue, meanwhile if it is perceived as so then you can relate to the grounds for this, that is, previous CR s, even with the assurance of no CR market may be concerned with Admedus acquiring debt.
From my laymans outlook, I would have no issue with this as long as the company is on the up and up, debt covering the shortfall to achieve fy20 vision.
Left field announcement would be great and am sure we will receive info across several fronts ..... whether such will appreciate the sp, time will tell.
My thoughts on AHZ, page-197
-
- There are more pages in this discussion • 45 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$10.75 |
Change
-0.110(1.01%) |
Mkt cap ! $227.2M | |||
| Open | High | Low | Value | Volume |
| $10.95 | $10.95 | $10.24 | $285.2K | 26.69K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | $10.49 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $10.75 | 413 | 1 |
View Market Depth
| Last trade - 16.10pm 31/10/2024 (20 minute delay) ? |
| AVR (ASX) Chart |